Affymax to create multiple presentations on preclinical and clinical data of Hematide Affymax.

Affymax and investigators will make multiple presentations highlighting Hematide preclinical and clinical data in various treatment settings. These include preliminary results of a Phase 2 trial in hemodialysis patients who aren’t on an erythropoiesis stimulating agent , and interim results from an ongoing Phase 2 study in individuals with antibody-mediated pure crimson cell aplasia . Related StoriesDiets abundant with potassium can help prevent heart and kidney problems in individuals with type 2 diabetesESRD patients with multiple myeloma living longer than before, displays studyAdvances in nanofilter technology can lead to implantable surgically, artificial kidneyDetails of Hematide presentations at ASN are the following: *Note: All instances are detailed in Pacific Time Company Webcast Affymax will sponsor an trader webcast with Dr.This feedback has significantly exceeded our expectations. ‘.

AANMA companions with AAE and AAPA-AAI to build network concentrating on allergy, asthma care Allergy & Asthma Network Moms of Asthmatics , a leading patient education organization, is partnering with the Association of Asthma Educators and the American Academy of Doctor Assistants in Allergy, Asthma & Immunology within its try to build the only multidisciplinary, patient-centered network of healthcare professionals focused on allergy and asthma treatment. Asthma educators and doctor assistants offer a wealth of knowledge and expertise to greatly help educate and advocate for sufferers with asthma and allergies, says Tonya Winders, AANMA Chief Operating Officer.